Randomised Controlled TrialtaVNSn = 50

Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers

Cui Y, Sun J, Zhang B, Guo T, Zhang S, Li Z, Chen Y, Su M, Wu D, Wu J, et al.

Molecular Psychiatry · 2025

Key finding

An RCT of taVNS for the persistent negative symptoms of treatment-resistant schizophrenia (detailed outcomes not in the indexed abstract).

Auto-extracted · verification pendingHow we verify

Condition
Schizophrenia
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
50
View on DOI

Share this study

Download the citation card as a PNG, or copy a link to this page.

Cite this study

Cui, Y., Sun, J., Zhang, B., Guo, T., Zhang, S., Li, Z., Chen, Y., Su, M., Wu, D., Wu, J., Wang, Q., Yuan, Y., Wang, J., Tian, Q., He, F., Wu, L., Li, X., Gong, Y., & Qin, W. (2025). Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers. Molecular Psychiatry, 30(11), 5437-5447. https://doi.org/10.1038/s41380-025-03132-8

Related studies in Schizophrenia

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.